Home HOME Neoplasma 2009 Neoplasma Vol.56, No.4, p.331-334, 2009

Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.56, No.4, p.331-334, 2009

Title: Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma
Author: H. J. BAE, J. H. SONG, J. H. NOH, J. K. KIM, K. H. JUNG, J. W. EUN, H. J. XIE, J. C. RYU, Y. M. AHN, S. Y. KIM, S. H. LEE, N. J. YOO, J. Y. LEE, W. S. PARK, S. W. NAM

Abstract: EphA3 is a component of the Eph/ephrin tyrosine kinase system, which participates in vasculature development. This receptor/ligand system is associated with various signaling pathways related to cell growth and viability, cytoskeletal organization, cell migration, and anti-apoptosis. Accumulated evidence suggests that aberrant regulation of EphA3 and its genetic alterations are implicated in the development and progression of various cancers. However, despite a high incidence of EphA3 over-expression, no such investigation has been performed in hepatocellular carcinoma. Thus, we investigated genetic alterations of the EphA3 gene in 73 cases of hepatocellular carcinoma by single-strand conformational polymorphism and sequencing. One novel D219V missense mutation was found in the extracellular domain of EphA3, and two genetic alterations in the intracellular sterile-α-motif (SAM) domain of EphA3 appeared to be polymorphisms. Although the functional assessments of this mutant are incomplete, it is believed that this novel EphA3 mutation may contribute to the development of hepatocellular carcinoma.

Keywords: Eph receptor, EphA3, hepatocellular carcinoma, mutation
Year: 2009, Volume: 56, Issue: 4 Page From: 331, Page To: 334

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.